デフォルト表紙
市場調査レポート
商品コード
1490323

製薬向け臨床試験サプライ&ロジスティクス市場:2024-2034年

Clinical Trial Supply and Logistics Market for Pharma 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 275 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=206.60円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

製薬向け臨床試験サプライ&ロジスティクス市場:2024-2034年
出版日: 2024年05月27日
発行: Visiongain Reports Ltd.
ページ情報: 英文 275 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の製薬向け臨床試験サプライ&ロジスティクスの市場規模は、2034年にかけてCAGR 9.3%で成長すると予測されています。

臨床試験における多様性の拡大:

臨床試験における多様性の向上は、あらゆる人々に対する医療介入の安全性と有効性を保証するために不可欠です。この必要性に対処するため、臨床試験施設とスポンサーは、臨床研究における多様性と包括性を奨励する積極的な措置を講じることで、重要な役割を果たすことができます。

当レポートでは、世界の製薬向け臨床試験サプライ&ロジスティクスの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 製薬向け臨床試験サプライ&ロジスティクス市場の分析:タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • CTS製造
  • CTSロジスティクス&ディストリビューション
  • CTサプライチェーンマネジメント
  • CTSパッケージング&ストレージ
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 製薬向け臨床試験サプライ&ロジスティクス市場の分析:フェーズ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 前臨床
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV
  • 販売後
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 製薬向け臨床試験サプライ&ロジスティクス市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測
  • 製薬向け臨床試験サプライ&ロジスティクス市場:地域別

第7章 北米の製薬向け臨床試験サプライ&ロジスティクス市場の分析

第8章 欧州の製薬向け臨床試験サプライ&ロジスティクス市場の分析

第9章 アジア太平洋の製薬向け臨床試験サプライ&ロジスティクス市場の分析

第10章 ラテンアメリカの製薬向け臨床試験サプライ&ロジスティクス市場の分析

第11章 中東・アフリカの製薬向け臨床試験サプライ&ロジスティクス市場の分析

第12章 企業プロファイル

  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • ICON plc
  • Eurofins Scientific
  • FedEx
  • United Parcel Service, Inc.
  • KERRY LOGISTICS NETWORK LIMITED
  • Kuehne+Nagel
  • Bilcare Limited
  • Mayne Pharma Group Limited
  • Intertek Group plc
  • Almac Group
  • Parexel International Corporation
  • Biocair
  • Marken(A UPS Company)
  • PCI Pharma Services(PCI)
  • Movianto
  • Yourway
  • COREX Logistics
  • Oximio
  • Royal Cargo
  • NAF Pharma

第13章 総論・提言

  • Visiongainによる総論
  • 市場参入企業への提言
図表

List of Tables

  • Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %): "V" Shaped Recovery
  • Table 3 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %): "U" Shaped Recovery
  • Table 4 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %): "W" Shaped Recovery
  • Table 5 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %): "L" Shaped Recovery
  • Table 6 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 7 CTS Manufacturing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 8 CTS Logistics & Distribution Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 9 CT Supply Chain Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 10 CTS Packaging & Storage Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 11 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 12 Preclinical Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 13 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 14 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 15 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 16 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 17 Post Launch Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 18 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 19 Biopharma Clinical Trial Supply and Logistics Market by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 20 North America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 21 North America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 22 North America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 23 U.S. Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 24 Canada Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 25 Europe Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 26 Europe Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 27 Europe Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 28 Germany Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 29 UK Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 30 France Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 31 Italy Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 32 Spain Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 33 Russia Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 34 Netherlands Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 35 Switzerland Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 36 Rest of Europe Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 37 Asia Pacific Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 38 Asia Pacific Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 39 Asia Pacific Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 40 Japan Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 41 China Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 42 India Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 43 Australia Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 44 South Korea Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 45 South-East Asia Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 46 Rest of Asia Pacific Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 47 Latin America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 48 Latin America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 49 Latin America Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 50 Brazil Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 51 Mexico Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 52 Argentina Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 53 Colombia Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 54 Rest of Latin America Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 55 MEA Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 56 MEA Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 57 MEA Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 58 GCC Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 59 South Africa Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 60 Rest of MEA Clinical Trial Supply and Logistics Market for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 61 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 62 Catalent, Inc.: Service Benchmarking
  • Table 63 Catalent, Inc.: Strategic Outlook
  • Table 64 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 65 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 66 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 67 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 68 ICON plc: Service Benchmarking
  • Table 69 ICON plc: Strategic Outlook
  • Table 70 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 71 Eurofins Scientific: Services Offered
  • Table 72 Eurofins Scientific: Strategic Outlook
  • Table 73 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 74 FedEx: Service Benchmarking
  • Table 75 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 United Parcel Service, Inc.: Service Benchmarking
  • Table 77 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 KERRY LOGISTICS NETWORK LIMITED: Service Benchmarking
  • Table 79 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Kuehne+Nagel: Service Benchmarking
  • Table 81 Kuehne+Nagel: Strategic Outlook
  • Table 82 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 Bilcare Limited: Service Benchmarking
  • Table 84 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Mayne Pharma Group Limited: Service Benchmarking
  • Table 86 Mayne Pharma Group Limited: Strategic Outlook
  • Table 87 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Intertek Group plc: Service Benchmarking
  • Table 89 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 90 Almac Group: Service Benchmarking
  • Table 91 Almac Group: Strategic Outlook
  • Table 92 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Parexel International Corporation: Service Benchmarking
  • Table 94 Parexel International Corporation: Strategic Outlook
  • Table 95 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Biocair: Service Benchmarking
  • Table 97 Biocair: Strategic Outlook
  • Table 98 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Marken (A UPS Company): Service Benchmarking
  • Table 100 Marken (A UPS Company): Strategic Outlook
  • Table 101 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 PCI Pharma Services (PCI): Service Benchmarking
  • Table 103 PCI Pharma Services (PCI): Strategic Outlook
  • Table 104 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Movianto: Service Benchmarking
  • Table 106 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Yourway: Service Benchmarking
  • Table 108 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 COREX Logistics: Service Benchmarking
  • Table 110 Oximio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Oximio: Service Benchmarking
  • Table 112 Royal Cargo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Royal Cargo: Service Benchmarking
  • Table 114 NAF Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 NAF Pharma: Service Benchmarking

List of Figures

  • Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
  • Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
  • Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
  • Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
  • Figure 5 Clinical Trials Supply and Logistics Market: Market Dynamics
  • Figure 6 Clinical Trials Initiated by Phase, 2023
  • Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 10 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 11 Clinical Trial Supply and Logistics for Pharma Market: Porter's Five Forces Analysis
  • Figure 12 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
  • Figure 13 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
  • Figure 14 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 15 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 16 CTS Manufacturing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 17 CTS Manufacturing Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 18 CTS Logistics & Distribution Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 19 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 CT Supply Chain Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 21 CT Supply Chain Management Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 CTS Packaging & Storage Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 23 CTS Packaging & Storage Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
  • Figure 25 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 26 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024, 2029, 2034 (%)
  • Figure 27 Preclinical Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 28 Preclinical Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 30 Phase I Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 32 Phase II Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 33 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 34 Phase III Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 35 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 36 Phase IV Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Post Launch Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 38 Post Launch Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 40 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 41 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 Clinical Trial Supply and Logistics for Pharma Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 43 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 49 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 50 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024 & 2034 (%)
  • Figure 51 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 52 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 59 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 60 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024 & 2034 (%)
  • Figure 61 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 62 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 63 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 64 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 65 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 66 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 67 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 68 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 69 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 70 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 74 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 75 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 76 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 77 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024 & 2034 (%)
  • Figure 78 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 79 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 81 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 85 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 89 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 90 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 91 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 92 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024 & 2034 (%)
  • Figure 93 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 94 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 95 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 97 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 98 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 100 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 101 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 102 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 103 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 104 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
  • Figure 105 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2024 & 2034 (%)
  • Figure 106 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 108 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 Catalent, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 110 Catalent, Inc.: Regional Market Shares, 2023
  • Figure 111 Thermo Fisher Scientific Inc: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 112 Thermo Fisher Scientific Inc: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 113 Thermo Fisher Scientific Inc: Regional Market Shares, 2023
  • Figure 114 ICON plc: Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 115 ICON plc: Regional Market Shares, 2023
  • Figure 116 Eurofins Scientific: Net Revenue, 2019-2022 (US$ Million, AGR %)
  • Figure 117 FedEx: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 118 FedEx: Regional Market Shares, 2023
  • Figure 119 United Parcel Service, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 120 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 121 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2023
  • Figure 122 Kuehne+Nagel: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 123 Kuehne+Nagel: Regional Market Shares, 2023
  • Figure 124 Bilcare Limited: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 125 Bilcare Limited: Regional Market Shares, 2022
  • Figure 126 Mayne Pharma Group Limited: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 127 Mayne Pharma Group Limited: Regional Market Shares, 2023
  • Figure 128 Intertek Group plc: Net Revenue, 2019-2023 (US$ Million, AGR %)
目次
Product Code: PHA1325

The global Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034

The Clinical Trial Supply and Logistics for Pharma Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancing Diversity in Clinical Trials

Improving diversity in clinical trials is essential to guaranteeing the safety and effectiveness of medical interventions for all populations. In order to address this imperative, sites and sponsors can play a crucial role by taking proactive steps to encourage diversity and inclusivity in clinical research.

In order to obtain deep insights into the priorities of patient communities, sites and sponsors must first give priority to community engagement. These insights can then be incorporated into study designs and logistical arrangements, such as offering remote and digitally enabled study participation.

Initiatives for community outreach should be long-term commitments that find and apply viable solutions, building confidence and reducing obstacles to participation for marginalised groups. By working together with community organisations, healthcare providers, and advocacy groups, researchers can better understand the social and political factors that influence health, cross linguistic and cultural barriers, spread the word about opportunities for clinical research, and allay fears and misconceptions.

It is recommended that clinical trials be designed with input from trial sites and patient communities in order to minimise barriers to participation and create inclusive eligibility criteria. Encouraging diverse participants by providing patient-centred, culturally competent care throughout the trial process creates a warm and encouraging atmosphere. Additionally, research staff should receive diversity training from sites and sponsors in order to address implicit biases, improve communication skills, and develop cultural sensitivity. Research teams can establish an equitable environment that promotes diverse participation in clinical trials by cultivating an inclusive and respectful culture.

What Questions Should You Ask before Buying a Market Research Report?

How is the clinical trial supply and logistics for pharma market evolving?

What is driving and restraining the clinical trial supply and logistics for pharma market?

How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the clinical trial supply and logistics for pharma projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?

Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:

Our 275-page report provides 115 tables and 128 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supply and logistics for pharma market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Type

CTS Manufacturing

CTS Logistics & Distribution

CT Supply Chain Management

CTS Packaging & Storage

Phase

Preclinical

Phase I

Phase II

Phase III

Phase IV

Post Launch

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Switzerland

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

South-East Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Almac Group

Bilcare Limited

Biocair

Catalent, Inc.

COREX Logistics

Eurofins Scientific

FedEx

ICON plc

Intertek Group plc

Kerry Logistics Network Limited

Kuehne+Nagel

Marken (A UPS Company)

Mayne Pharma Group Limited

Movianto

NAF Pharma

Oximio

Parexel International Corporation

PCI Pharma Services (PCI)

Royal Cargo

Thermo Fisher Scientific Inc.

United Parcel Service, Inc.

Yourway

Overall world revenue for Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 in terms of value the market will surpass US$14.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 report help you?

In summary, our 270+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Clinical Trial Supply and Logistics for Pharma Market 2024 to 2034, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Move Towards Decentralized/Virtual Trials
      • 3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
      • 3.2.1.3 Growing Clinical Trials Volume
      • 3.2.1.4 Integrated Solution to Track Clinical Trials
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
      • 3.2.2.2 Man-made or Natural Disruption in Transportation
      • 3.2.2.3 High Financial Cost
    • 3.2.3 Market Opportunities
      • 3.2.3.1 AI and Machine Learning are Evolving with More Data
      • 3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
      • 3.2.3.3 Big Companies are driving the Market
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 4.4 CTS Manufacturing
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 CTS Logistics & Distribution
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 CT Supply Chain Management
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 CTS Packaging & Storage
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase

  • 5.1 Key Findings
  • 5.2 Phase Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 5.4 Preclinical
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Phase I
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Phase II
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Phase III
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Phase IV
    • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Post Launch
    • 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)

6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast
  • 6.3 Biopharma Clinical Trial Supply and Logistics Market by Region

7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis

8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

12 Company Profiles

  • 12.1 Catalent, Inc.
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Financial Analysis
      • 12.1.3.1 Net Revenue, 2019-2023
      • 12.1.3.2 Regional Market Shares, 2023
    • 12.1.4 Service Benchmarking
    • 12.1.5 Strategic Outlook
  • 12.2 Thermo Fisher Scientific Inc.
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Financial Analysis
      • 12.2.3.1 Net Revenue, 2019-2023
      • 12.2.3.2 R&D, 2019-2023
      • 12.2.3.3 Regional Market Shares, 2023
    • 12.2.4 Service Benchmarking
    • 12.2.5 Strategic Outlook
  • 12.3 ICON plc
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Financial Analysis
      • 12.3.3.1 Revenue, 2019-2023
      • 12.3.3.2 Regional Market Shares, 2023
    • 12.3.4 Service Benchmarking
    • 12.3.5 Strategic Outlook
  • 12.4 Eurofins Scientific
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Financial Analysis
      • 12.4.3.1 Net Revenue, 2019-2022
    • 12.4.4 Services Offered
    • 12.4.5 Strategic Outlook
  • 12.5 FedEx
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Financial Analysis
      • 12.5.3.1 Net Revenue, 2019-2023
      • 12.5.3.2 Regional Market Shares, 2023
    • 12.5.4 Service Benchmarking
  • 12.6 United Parcel Service, Inc.
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
      • 12.6.3.1 Net Revenue, 2019-2023
    • 12.6.4 Service Benchmarking
  • 12.7 KERRY LOGISTICS NETWORK LIMITED
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Financial Analysis
      • 12.7.3.1 Net Revenue, 2019-2023
      • 12.7.3.2 Regional Market Shares, 2023
    • 12.7.4 Service Benchmarking
  • 12.8 Kuehne+Nagel
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Financial Analysis
      • 12.8.3.1 Net Revenue, 2019-2023
      • 12.8.3.2 Regional Market Shares, 2023
    • 12.8.4 Service Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Bilcare Limited
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Financial Analysis
      • 12.9.3.1 Net Revenue, 2018-2022
      • 12.9.3.2 Regional Market Shares, 2022
    • 12.9.4 Service Benchmarking
  • 12.10 Mayne Pharma Group Limited
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Financial Analysis
      • 12.10.3.1 Net Revenue, 2019-2023
      • 12.10.3.2 Regional Market Shares, 2023
    • 12.10.4 Service Benchmarking
    • 12.10.5 Strategic Outlook
  • 12.11 Intertek Group plc
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Financial Analysis
      • 12.11.3.1 Net Revenue, 2019-2023
    • 12.11.4 Service Benchmarking
  • 12.12 Almac Group
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Service Benchmarking
    • 12.12.4 Strategic Outlook
  • 12.13 Parexel International Corporation
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Service Benchmarking
    • 12.13.4 Strategic Outlook
  • 12.14 Biocair
    • 12.14.1 Company Snapshot
    • 12.14.2 Company Overview
    • 12.14.3 Service Benchmarking
    • 12.14.4 Strategic Outlook
  • 12.15 Marken (A UPS Company)
    • 12.15.1 Company Snapshot
    • 12.15.2 Company Overview
    • 12.15.3 Service Benchmarking
    • 12.15.4 Strategic Outlook
  • 12.16 PCI Pharma Services (PCI)
    • 12.16.1 Company Snapshot
    • 12.16.2 Company Overview
    • 12.16.3 Service Benchmarking
    • 12.16.4 Strategic Outlook
  • 12.17 Movianto
    • 12.17.1 Company Snapshot
    • 12.17.2 Company Overview
    • 12.17.3 Service Benchmarking
  • 12.18 Yourway
    • 12.18.1 Company Snapshot
    • 12.18.2 Company Overview
    • 12.18.3 Service Benchmarking
  • 12.19 COREX Logistics
    • 12.19.1 Company Snapshot
    • 12.19.2 Company Overview
    • 12.19.3 Service Benchmarking
  • 12.20 Oximio
    • 12.20.1 Company Snapshot
    • 12.20.2 Company Overview
    • 12.20.3 Service Benchmarking
  • 12.21 Royal Cargo
    • 12.21.1 Company Snapshot
    • 12.21.2 Company Overview
    • 12.21.3 Service Benchmarking
  • 12.22 NAF Pharma
    • 12.22.1 Company Snapshot
    • 12.22.2 Company Overview
    • 12.22.3 Service Benchmarking

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players